Form 4: Chemours Director Boosts Equity Holdings

Chemours Director Courtney Mather acquired 1,657 deferred stock units, increasing direct beneficial ownership to 3,960.9731 units, as part of a pre-arranged plan.

Summary

• Courtney Mather, a Director of The Chemours Company (CC), acquired 1,657 Deferred Stock Units (DSUs).
• The transaction date for this acquisition was September 30, 2025.
• Each DSU is the economic equivalent of one share of Chemours' common stock.
• The DSUs were acquired at an economic equivalent price of $15.84 per unit.
• Following this transaction, Courtney Mather directly beneficially owns 3,960.9731 Deferred Stock Units.
• The DSUs become payable upon the first month following the Reporting Person's termination of service as a director.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The acquisition of deferred stock units by a director is generally viewed positively as it indicates alignment of interests and confidence in the company's future, though it's a routine compensation event rather than a significant new investment.

Positives

• A director's acquisition of additional equity, even in the form of deferred stock units, can signal confidence in the company's future performance.
• The transaction aligns the director's financial interests more closely with those of the shareholders.

Future Outlook

The acquired deferred stock units will become payable upon the first month following the reporting person's termination of service as a director.

Industry Context

Insider transactions, particularly equity grants or acquisitions by directors, are a common practice in publicly traded companies. They are often part of executive and director compensation packages designed to align leadership interests with shareholder value creation.

Comparison to Industry Standards

• Director equity ownership, often through mechanisms like deferred stock units, is a standard corporate governance practice across industries, including the chemicals sector where Chemours operates.
• The use of Rule 10b5-1 plans for pre-arranged transactions is also a common and accepted method for insiders to manage their equity holdings in compliance with insider trading regulations.

Related Party Transactions

• The acquisition of deferred stock units by a director from the issuer constitutes a related party transaction, which is a standard component of director compensation.

Stakeholder Impact

• Shareholders: The transaction enhances alignment between the director's financial interests and shareholder value, potentially fostering more shareholder-centric decision-making.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The deferred stock units will become payable to Courtney Mather upon the first month following termination of service as a director.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of deferred stock units by a director, which is a common form of equity compensation and generally viewed positively as it aligns director interests with shareholders. However, it does not provide new fundamental information to warrant a change in investment recommendation.

Keywords

Chemours, CC, Insider Transaction, Deferred Stock Units, Director, Equity Acquisition, Form 4, 10b5-1 Plan